Medtronic (MDT) Shares Outstanding (Weighted Average) (2013 - 2026)

Medtronic's Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.36% year-over-year to $1.3 billion; the TTM figure through Jan 2026 stood at $1.3 billion (changed 0.36% YoY), while the FY2025 annual figure was $1.3 billion, down 3.17% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.3 billion for Q1 2026 at Medtronic, roughly flat from $1.3 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2022 to a low of $1.3 billion in Q3 2025.
• A 5-year average of $1.3 billion and a median of $1.3 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) advanced 0.08% in 2023 and declined 3.23% in 2025, its largest moves.
• Medtronic's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then rose by 0.07% to $1.3 billion in 2023, then slipped by 3.13% to $1.3 billion in 2024, then fell by 0.51% to $1.3 billion in 2025, then increased by 0.01% to $1.3 billion in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison